| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $595.3M | -2.1% |
| Cost of Revenue | $1.94B | +17.6% |
| R&D Expense | $937.0M | +14.1% |
| SG&A Expense | $797.2M | +8.5% |
| Operating Income | -$3.10B | -19.5% |
| Interest Expense | $24.9M | -18.6% |
| Pre-tax Income | -$2.83B | -116.8% |
| Income Tax | $1.0M | +170.7% |
| Net Income | -$2.83B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.37B | -21.1% |
| Short-term Investments | $2.49B | +14.4% |
| Accounts Receivable | $51.8M | +165.2% |
| Inventory | $696.2M | -16.6% |
| Current Assets | $4.76B | -3.2% |
| Total Assets | $8.51B | +8.0% |
| Current Liabilities | $1.01B | +7.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.49B | -11.8% |
| Capital Expenditures | $910.6M | -15.3% |
| Investing Cash Flow | -$947.0M | +74.3% |
| Financing Cash Flow | $3.07B | +127.9% |
| Free Cash Flow | -$3.40B | -3.0% |
| -116.8% |
| EPS (Basic) | -$1.36 | -74.4% |
| EPS (Diluted) | -$1.36 | +9.9% |
| Long-term Debt |
| $2.00B |
| +0.3% |
| Total Liabilities | $3.66B | +3.7% |
| Stockholders' Equity | $4.85B | +11.5% |